NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 51 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $504,500 | -2.7% | 2,727,027 | 0.0% | 0.03% | -25.0% |
| Q4 2022 | $518,681 | -51.8% | 2,727,027 | 0.0% | 0.04% | -52.6% |
| Q3 2022 | $1,077,000 | -62.4% | 2,727,027 | 0.0% | 0.08% | -65.9% |
| Q2 2022 | $2,863,000 | -44.2% | 2,727,027 | 0.0% | 0.22% | -31.6% |
| Q1 2022 | $5,127,000 | -33.1% | 2,727,027 | 0.0% | 0.33% | -25.6% |
| Q4 2021 | $7,663,000 | -22.2% | 2,727,027 | 0.0% | 0.44% | -33.6% |
| Q3 2021 | $9,844,000 | -24.6% | 2,727,027 | 0.0% | 0.66% | -19.5% |
| Q2 2021 | $13,062,000 | -12.8% | 2,727,027 | +34.5% | 0.82% | -21.4% |
| Q1 2021 | $14,980,000 | +5.7% | 2,027,027 | 0.0% | 1.04% | +22.4% |
| Q4 2020 | $14,169,000 | -7.9% | 2,027,027 | 0.0% | 0.85% | -32.2% |
| Q3 2020 | $15,386,000 | -7.9% | 2,027,027 | +6.5% | 1.26% | -30.7% |
| Q2 2020 | $16,711,000 | +52.6% | 1,903,227 | +23.7% | 1.81% | +16.1% |
| Q1 2020 | $10,954,000 | -1.1% | 1,538,462 | 0.0% | 1.56% | +89.9% |
| Q4 2019 | $11,077,000 | +44.3% | 1,538,462 | 0.0% | 0.82% | +48.9% |
| Q3 2019 | $7,677,000 | – | 1,538,462 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
| Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
| GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
| Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
| Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
| Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |